CN Patent

CN102105459A — 作为蛋白激酶抑制剂的3,4-二芳基吡唑类

Assigned to Lsi Braafsap LLC · Expires 2011-06-22 · 15y expired

What this patent protects

公开了如本说明书所定义的式(I)的3，4-二芳基吡唑衍生物及其药学可接受的盐、及其制备方法和包含它们的药物组合物；本发明的化合物可以在疗法中用于治疗于蛋白激酶活性失调相关的疾病，如癌症。

USPTO Abstract

公开了如本说明书所定义的式(I)的3，4-二芳基吡唑衍生物及其药学可接受的盐、及其制备方法和包含它们的药物组合物；本发明的化合物可以在疗法中用于治疗于蛋白激酶活性失调相关的疾病，如癌症。

Drugs covered by this patent

Patent Metadata

Patent number
CN102105459A
Jurisdiction
CN
Classification
—
Expires
2011-06-22
Drug substance claim
No
Drug product claim
No
Assignee
Lsi Braafsap LLC
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.